臨床婦人科産科71巻10号

2017年10月発行

今月の臨床 最新！　婦人科がん薬物療法─化学療法薬から分子標的薬・免疫療法薬まで

子宮頸がん

子宮頸がん術後の補助化学療法は放射線治療と比較してどうか

著者： 的田眞紀¹ 谷川輝美¹ 竹島信宏¹

所属機関： ¹がん研有明病院婦人科

ページ範囲：P.960 - P.966

文献概要

●子宮頸がんで推奨される術後補助療法は，高リスク群に対して同時化学放射線療法（CCRT），中リスク群には放射線療法でリスク因子の数・程度によってはCCRTも考慮することになっており，化学療法単独治療は推奨されていない．

●子宮頸がん術後の補助化学療法の有用性は確立していないが，治癒が期待できる早期子宮頸がんにおいては，治療効果があり，長期の有害事象が少ない化学療法の適応は十分に検討されていくべきであろう．

参考文献

1）Sedlis A, et al : A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage Ib carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy : A Gynecologic Oncology Group Study. Gynecol Oncol 73 : 177─183, 1999

2）Micha JP, et al : Surgery alone or surgery with a combination radiation or chemoradiation for management of patients with bulky-stage Ib2 cervical carcinoma. Int J Gynecol Cancer 16 : 1147─1151, 2006

3）Takeshima N, et al : Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage Ib-IIA cervical cancer. Gynecol Oncol 103 : 618─622, 2006

4）Hosaka M, et al : Treatment of cervical cancer with adjuvant chemotherapy versus adjuvant radiotherapy after radical hysterectomy and systematic lymphadenectomy. J Obstet Gynaecol Res 34 : 552─556, 2008

5）Hosaka M, et al : Clinical efficacy of paclitaxel/cisplatin as an adjuvant chemotherapy for patients with cervical cancer who underwent radical hysterectomy and systematic lymphadenectomy. J Surg Oncol 105 : 612─616, 2012

6）Peters WA, et al : Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18 :1606─1613, 2000

7）Angioli R, et al : Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer. Gynecol Oncol 127 : 290─296, 2012

8）Tattersall MH, et al : A randomized trial of adjuvant chemotherapy after radical hysterectomy in stage Ib-IIa cervical cancer patients with pelvic lymph node metastases. Gynecol Oncol 46 : 176─181, 1992

9）Curtin JP, et al : Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy（RH-PLND）: a randomized phase III trial. Gynecol Oncol 61 : 3─10, 1996

10）Lahousen M, et al : Chemotherapy versus radiotherapy versus observation for high-risk cervical carcinoma after radical hysterectomy : A randomized, prospective, multicenter trial. Gynecol Oncol 73 : 196─201, 1999

11）Sehouli JA, et al : randomized phase III adjuvant study in high-risk cervical cancer : simultaneous radiochemotherapy with cisplatin（S-RC） versus systemic paclitaxel and carboplatin followed by percutaneous radiation（PC-R） : a NOGGO-AGO Intergroup Study. Ann Oncol 23 : 2259─2264, 2012